Alnylam Pharmace. buy klostergang
Start price
01.10.19
/
50%
€71.64
Target price
04.11.21
€150.00
Performance (%)
96.54%
End price
17.06.21
€140.80
Summary
This prediction ended on 17.06.21 with a price of €140.80. With a performance of 96.54% the BUY prediction by klostergang was a big success. klostergang has 50% into this predictionAlnylam Pharmaceuticals, Inc. (ALNY) is a biopharmaceutical company focused on the development of RNA interference (RNAi) therapeutics. Its lead drug, ONPATTRO®, is approved by the U.S. FDA for the treatment of adults with polyneuropathy of hereditary transthyretin-mediated (hATTR) amyloidosis. The company is also developing additional RNAi therapeutic candidates for the treatment of a range of diseases, including cancer, cardiovascular disease, and viral infections. With a market capitalization of over $15 billion, Alnylam is one of the largest biotech companies in the world.
Performance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Alnylam Pharmace. | -1.233% | -1.233% | 36.780% | 45.135% |
| iShares Core DAX® | 3.011% | 1.442% | 22.848% | 50.829% |
| iShares Nasdaq 100 | 3.009% | 0.574% | 37.061% | 80.368% |
| iShares Nikkei 225® | 4.142% | 4.547% | 53.856% | 60.399% |
| iShares S&P 500 | 2.378% | 0.244% | 29.012% | 59.977% |
Comments by klostergang for this prediction
In the thread Alnylam Pharmace. diskutieren
Buy mit Kursziel 130,0
Kursziel geändert auf 140,0
Kursziel geändert auf 150,0